Research shows that adults experiencing perceived taste loss face a higher risk of mortality, particularly when the ability to detect salt and sourness declines.
The U.S. Food and Drug Administration has approved Onapgo, a continuous apomorphine hydrochloride infusion, for the treatment of motor fluctuations in adult patients with advanced Parkinson’s disease.
Key trial data and insights behind US Food and Drug Administration approvals of novel psychiatric drugs are shown, highlighting methods, demographics, and pivotal outcomes.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
A new study exposes the alarming levels of medical and educational debt burdening U.S. health care workers, with debt disproportionately affecting women, Black workers, and those in lower-paying fields.
NIH director, Dr. Monica M. Bertagnolli, is stepping down after launching major initiatives in women's health and long COVID research, indicating optimism for their continuation under new leadership.